Comparative-Effectiveness Research in Molecular Imaging

Tuesday, June 7 | 2:30 PM - 4:00 PM
Room 006CD

Objectives
Upon completion of this activity, the participant will be able to:
1. Assess and interpret comparative-effectiveness research (CER) studies in terms of type of study design, research perspective, comparison groups, sub-population studied, primary findings, limitations and implications.
2. Develop CER study questions in molecular imaging modalities and develop hypotheses for and approaches to CER.
3. Discuss completely the broad implications of CER in molecular imaging and in medicine.

Speakers are:
Michael M. Graham, PhD, MD, University of Iowa Carver College of Medicine in Iowa City, Iowa;
Brian W. Bresnahan, PhD, Harborview Medical Center in Seattle; and
Daniel H. Silverman, MD, PhD, University of California, Los Angeles.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.